Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
SE
Sera Prognostics, Inc. Class A Common Stock
SERA
Mkt Cap
$80.6M
Volume
3.00K
Next Earnings
November 12th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
SE
SERA
SE
Sera Prognostics, Inc. Class A Common Stock
SERA
News
·
Elevance Health (ELV) Rallies 11.8% YTD: More Room to Run?
Mkt Cap
$81.3M
Volume
3.00K
Next Earnings
November 12th
Chart
Financials
Earnings
News
About
Insider
Filings
Elevance Health (ELV) Rallies 11.8% YTD: More Room to Run?
Elevance Health's (ELV) performance benefits from new contract wins, a strong Carelon segment and recovering Medicaid business.
Zacks Investment Research · Jun 20, 2024
Brookdale (BKD) Sees 31 Months of Y/Y Occupancy Growth Streak
Brookdale's (BKD) weighted average occupancy for the second quarter-to-date rises 160 bps year over year to 78%.
Zacks Investment Research · Jun 11, 2024
Select Medical (SEM) Rises 42.4% YTD: More Growth Ahead?
Select Medical (SEM) will continue to gain from rising admissions within the Critical Illness Recovery Hospital and Rehabilitation Hospital segments.
Zacks Investment Research · Jun 10, 2024
Will UnitedHealth (UNH) Dividend Hike Fail to Excite Investors?
UnitedHealth's (UNH) strong financial position supports its shareholder value boosting efforts.
Zacks Investment Research · Jun 10, 2024
Cigna's (CI) Express Scripts Collaborates With CPESN USA
Cigna's (CI) Express Scripts collaborates with CPESN USA in a bid to enhance care delivery for hypertension and diabetes patients.
Zacks Investment Research · May 27, 2024
Encompass Health (EHC) JV Opens Atlanta Rehabilitation Hospital
The new facility in Georgia marks the 162nd inpatient rehabilitation hospital of Encompass Health (EHC) in the country.
Zacks Investment Research · May 24, 2024
Encompass Health (EHC) Opens Rehabilitation Hospital in Ballwin
The 40-bed inpatient rehabilitation hospital is a JV between Encompass Health (EHC) and BJC HealthCare.
Zacks Investment Research · May 22, 2024
Elevance (ELV) Rises 14.9% YTD: What Lies Ahead for Investors?
Elevance (ELV) continues to focus on increasing shareholder value with consistent dividend payouts and stock repurchases.
Zacks Investment Research · May 21, 2024
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings. Net revenue (managed) of $42.5 billion (+8% Y/Y), beating the consensus of $41.8 billion. Excluding an item resulted in an increase of $550 million (after tax) to reported net income from $13.4 billion to $14.0 billion and an increase of $0.19 per share to reported EPS from $4.44 to $4.63. EPS was $4.44, beating the consensus of $4.15. JPMorgan Chase shares dipped 5.1% to $185.49 on Friday. Here are some other stocks moving in today's mid-day session. Gainers PaxMedica, Inc. (NASDAQ: PXMD) jumped 143% to $1.0101 after the company announced the completed execution of its three pivotal registration/validation batches of PAX-101. EZGO Technologies Ltd. (NASDAQ: EZGO) gained 83.3% to $2.86. EZGO entered into a $1.84 million procurement agreement for sale of security patrol robots and platform. Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares jumped 58.8% to $3.6550 after dipping 29% on Thursday. Allarity Therapeutics filed prospectus supplement to increase offering price of common stock that may be offered from $1.4 million to $2.4 million. Beneficient (NASDAQ: BENF) rose 45.5% to $0.1006 after dipping around 10% on Thursday. NextPlat Corp (NASDAQ: NXPL) shares jumped 44% to $2.1799 after the company reported a year-over-year increase in FY23 consolidated revenue results. NextPlat announced a proposed business combination with Progressive Care Inc. HUB Cyber Security Ltd. (NASDAQ: HUBC) gained 31.6% to $1.54. 9F Inc. (NASDAQ: JFU) surged 25.1% to $3.63. Hanryu Holdings, Inc. (NASDAQ: HRYU) surged 25% to $0.51. Argan, Inc. (NYSE: AGX) gained 21.5% to $59.97 as the company reported better-than-expected results for its fourth quarter on Thursday. Rent the Runway, Inc. (NASDAQ: RENT) gained 19.6% to $23.55. Rent the Runway shares jumped 162% ...
Benzinga · Apr 12, 2024
Sera Prognostics (SERA) Upgraded to Buy: Here's What You Should Know
Sera Prognostics (SERA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks Investment Research · Mar 25, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
SE
SERA
Sera Prognostics, Inc. Class A Common Stock
Buy
Sell
Market
Limit
Soon
SERA
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any SERA yet.
Related Tickers
Earnings